Erschienen in:
20.12.2017 | Original Article
Predictors for a further local in-brain progression after re-craniotomy of locally recurrent cerebral metastases
verfasst von:
Marcel A. Kamp, Igor Fischer, Maxine Dibué-Adjei, Christopher Munoz-Bendix, Jan-Frederick Cornelius, Hans-Jakob Steiger, Philipp J. Slotty, Bernd Turowski, Marion Rapp, Michael Sabel
Erschienen in:
Neurosurgical Review
|
Ausgabe 3/2018
Einloggen, um Zugang zu erhalten
Abstract
Treatment of recurrent cerebral metastases is an emerging challenge due to the high local failure rate after surgery or radiosurgery and the improved prognosis of patients with malignancies. A total of 36 patients with 37 metastases who underwent surgery for a local in-brain progression of a cerebral metastasis after previous metastasectomy were retrospectively analyzed. Degree of surgical resection on an early postoperative MRI within 72 h after surgery was correlated with the local in-brain progression rate and overall survival. Complete surgical resection of locally recurrent cerebral metastases as confirmed by early postoperative MRI could only be achieved in 37.8%. Detection of residual tumor tissue on an early MRI following recurrent metastasis surgery correlated with further local in-brain progression when defining a significance level of p = 0.05 but not after Šidák or Bonferroni significance level correction for multiple testing: However, definite local tumor control could finally be achieved in 91.9% after adjuvant therapy. Overall survival after recurrent metastasectomy was significantly higher as predicted by diagnosis-specific graded prognostic assessment (12.9 ± 2.3 vs. 8.4 ± 0.7 months; p < 0.0001). However, our series involved a limited number of heterogeneous patients. A larger, prospective, and controlled study is required. Considering the adequate local tumor control achieved in the vast majority of patients, surgery of recurrent metastases may represent one option in a multi-modal treatment approach of patients suffering from locally recurrent cerebral metastases.